Gadia, Viviano S.
HRN: 23-28-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2023
07/09/2023
IV
2.25g
Q6
Sepsis Multifactorial: CAP-HR, Sacral Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose